Tsuruga Nursing University, Tsuruga, Japan.
Department of Neuropsychiatry, Kyorin University, School of Medicine, Mitaka, Japan.
Prim Health Care Res Dev. 2022 Aug 3;23:e42. doi: 10.1017/S1463423622000032.
The aim of this pilot study is to evaluate a Japanese version of brief Cognitive Behavioral Therapy for Insomnia (CBT-I) and contribute to primary care which leads to prevention of a lifestyle-related disease or a psychiatric disorder.
A single-arm study in nine patients with chronic insomnia who were under the pharmacotherapy was executed. The Insomnia Severity Index (ISI), the Athens Insomnia Scale (AIS), and the European Quality of Life 5 Items (EQ-5D) were assessed at the beginning of intervention, at the end of intervention, and after 12 weeks.
There were no patient dropouts nor adverse events. The average change in ISI score was -7.33 (95% CI: -10.31 to -4.36) at post-treatment and -6.11 (95% CI: -8.20 to -4.03) at the 12-week follow-up point (Cohen's d = 2.25). The AIS score improved as well, and the EQ-5D score improved after 12 weeks. The safety and efficacy of the brief CBT-I were suggested.
本初步研究旨在评估失眠的简短认知行为疗法（CBT-I）的日文版本，并为初级保健做出贡献，从而预防与生活方式相关的疾病或精神障碍。
对 9 名正在接受药物治疗的慢性失眠患者进行单臂研究。在干预开始时、干预结束时和 12 周后评估失眠严重程度指数（ISI）、雅典失眠量表（AIS）和欧洲生活质量 5 项（EQ-5D）。
无患者脱落或不良事件。治疗后 ISI 评分平均下降 7.33（95%CI：-10.31 至-4.36），12 周随访时下降 6.11（95%CI：-8.20 至-4.03）（Cohen's d = 2.25）。AIS 评分也有所改善，EQ-5D 评分在 12 周后有所改善。简短的 CBT-I 的安全性和有效性得到了提示。
